Forte Biosciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015
Revenue	0	0	0	0	0	18.04	0.04	0.05	0.05
Revenue Growth (YoY)	-	-	-	-	-	43890.24%	-16.33%	-3.92%	-
Gross Profit	0	0	0	0	0	18.04	0.04	0.05	0.05
Selling, General & Admin	10.62	8.3	7.63	4.22	1.38	12.81	8.56	4.52	3.83
Research & Development	21.86	5.59	13.85	10	2.68	51.08	29.11	27.22	19.17
Other Operating Expenses	0	0	0	32.06	0	0	0	0	0
Operating Expenses	32.49	13.9	21.49	46.28	4.06	63.89	37.67	31.74	23.01
Operating Income	-32.49	-13.9	-21.49	-46.28	-4.06	-45.85	-37.63	-31.69	-22.95
Interest Expense / Income	0	0	0	0	0	2.93	1.93	2.05	0.34
Other Expense / Income	-1.01	-0.02	0.22	0.21	0.01	-1.53	-0.63	-0.27	-0.24
Pretax Income	-31.48	-13.88	-21.71	-46.49	-4.07	-47.26	-38.93	-33.48	-23.06
Income Tax	0	0	0	0	0	1.7	0	0	0
Net Income	-31.48	-13.88	-21.71	-46.49	-4.07	-48.96	-38.93	-33.48	-23.06
Shares Outstanding (Basic)	32	17	14	7	2	1	1	0	0
Shares Outstanding (Diluted)	32	17	14	7	2	1	1	0	0
Shares Change	81.61%	24.45%	89.81%	249.05%	57.65%	37.32%	563.99%	0.82%	-
EPS (Basic)	-1.00	-0.80	-1.55	-6.32	-1.93	-36.60	-39.90	-228.30	-158.55
EPS (Diluted)	-1.00	-0.80	-1.55	-6.32	-1.93	-36.60	-39.90	-228.30	-158.55
Free Cash Flow	-28.79	-8.19	-16.68	-18.42	-2.93	-36.44	-31.77	-30.06	-21.26
Free Cash Flow Per Share	-0.91	-0.47	-1.19	-2.50	-1.39	-27.25	-32.62	-204.98	-146.13
Gross Margin	-	-	-	-	-	100.00%	100.00%	100.00%	100.00%
Operating Margin	-	-	-	-	-	-254.23%	-91775.61%	-64673.47%	-45007.84%
Profit Margin	-	-	-	-	-	-271.43%	-94948.78%	-68322.45%	-45207.84%
Free Cash Flow Margin	-	-	-	-	-	-202.02%	-77482.93%	-61355.10%	-41682.35%
EBITDA	-31.47	-13.88	-21.67	-46.43	-4.06	-43.7	-36.7	-31.17	-22.49
EBITDA Margin	-	-	-	-	-	-242.30%	-89521.95%	-63612.24%	-44088.24%
Depreciation & Amortization	0.01	0	0.04	0.05	0.01	0.63	0.29	0.26	0.23
EBIT	-31.48	-13.88	-21.71	-46.49	-4.07	-44.33	-37	-31.43	-22.72
EBIT Margin	-	-	-	-	-	-245.76%	-90234.15%	-64132.65%	-44543.14%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).